EAN 2026 | One big question with Manuel Toledo: what epilepsy advance could transform care in the next 3 years?

Manuel Toledo, MD, PhD, VHIR Vall d’Hebron Institut de Recerca, Barcelona, Spain, discusses the key advances in epilepsy that could transform care in the next three years. Dr Toledo highlights the development of more patient-friendly seizure monitoring devices as a major near-term advancement, while noting that disease-modifying therapies represent one of the most promising long-term goals for epilepsy treatment. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.